Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab

ClinicalTrials.gov ID: NCT04537429

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04537429. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 16, 2026, 1:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Single-dose, Pharmacokinetic Study to Evaluate IV Eptinezumab in Children and Adolescents With Migraine, Followed by an Optional, Multiple-dose, Open-label Extension Period

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to investigate how the body absorbs, distributes, and get rid of eptinezumab when given directly into a vein.

Study identification

NCT ID
NCT04537429
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
28 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 4, 2020 (Actual)
Primary completion
Oct 20, 2022 (Actual)
Completion
Aug 21, 2023 (Actual)
Last update posted
Oct 6, 2023

2020 – 2023

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
New England Institute for Clinical Research Stamford Connecticut 06905 —
NW FL Clinical Research Group LLC Gulf Breeze Florida 32561 —
The Premiere Research Institute at Palm Beach Neurology West Palm Beach Florida 33407-3234 —
College Park Family Care Center Overland Park Kansas 66212 —
Michigan Head Pain and Neurological Institute Ann Arbor Michigan 48104 —
Preferred Primary Care Physicians Inc. Pittsburgh Pennsylvania 15236-4604 —
North Texas Institute of Neurology & Headache Frisco Texas 75034 —
Road Runner Research Ltd San Antonio Texas 78249 —
Wasatch Clinical Research Salt Lake City Utah 84107 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04537429, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 6, 2023 · Synced Nov 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.